Quantum Genomics Societe Anonyme (0D1J) Financial Statements
Quantum Genomics Societe Anonyme Financial Overview
Quantum Genomics Societe Anonyme's market cap is currently $5.01M. The company's EPS TTM is $-0.25; its P/E ratio is -0.55; Quantum Genomics Societe Anonyme has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 10.00 | $ 19.80K | $ 2.52M | $ 3.14M | $ 1.83M |
| Gross Profit | $ -1.15M | $ -1.42M | $ -26.99M | $ -17.21M | $ -14.90M |
| Operating Income | $ -1.47M | $ -3.14M | $ -30.08M | $ -20.11M | $ -16.83M |
| EBITDA | $ -1.47M | $ -3.13M | $ -30.20M | $ -19.41M | $ -14.67M |
| Net Income | $ -8.89M | $ -3.17M | $ -24.94M | $ -17.36M | $ -16.22M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 301.02K | $ 3.55M | $ 10.40M | $ 13.55M | $ 27.15M |
| Total Assets | $ 354.65K | $ 3.75M | $ 23.66M | $ 21.24M | $ 32.80M |
| Total Debt | $ 2.64M | $ 2.72M | $ 3.03M | $ 3.46M | $ 884.00K |
| Net Debt | $ 2.34M | $ -830.55K | $ -7.37M | $ -10.09M | $ -26.27M |
| Total Liabilities | $ 2.81M | $ 3.31M | $ 20.05M | $ 11.57M | $ 8.15M |
| Stockholders' Equity | $ -2.46M | $ 436.66K | $ 3.61M | $ 9.67M | $ 24.65M |
| Cash Flow | |||||
| Free Cash Flow | $ 0.00 | $ 0.00 | $ -20.21M | $ -17.06M | $ -12.40M |
| Operating Cash Flow | $ 0.00 | $ 0.00 | $ -20.21M | $ -17.02M | $ -11.99M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ -152.54K | $ -45.00K | $ -411.00K |
| Financing Cash Flow | $ 0.00 | $ 0.00 | $ 17.21M | $ 3.46M | $ 28.39M |
Currency in EUR
